RxDoctor Payments Data

Randolph Schaffer, MD

Transplant Surgery · Worcester, MANPI 1639141690

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medical Device Business Services, Inc. at 27.3% of the total. Reporting peaked in 2019 at $1,922 and has fallen 88.6% since, to $218 in 2025.

$5,202in general payments, 2019–2025

Across 46 payments — averaging $113.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Intuitive Surgical$1K
  • Transmedics, Inc.$1K
  • Gilead$402
  • Organox Ltd$215
  • Boston Scientific$170
  • plus $433 from 16 others
$4,352in research payments, 2019–2025

Across 3 payments — averaging $1450.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$4K

What the payments were for

  • Travel & lodging$3,10360%
  • Food & beverage$2,07740%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,202 in reported general payments places this provider in the 70th percentile of 23 transplant surgery providers in Massachusetts.

See all transplant surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$128,773
Medicare patients
86
Services billed
312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl28$3,157
Ursodiol27$2,354
Tacrolimus12$2,264
Fluconazole18$315
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim46$163
Pantoprazole Sodium12$135
Acyclovir14$112
Famotidine17$82
Furosemide19$58
Amlodipine Besylate18$30

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →